Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by 허승범, Chairman & CEO. Officer active across 2 companies, notably 삼일제약. In total, 62 reports have been recorded. Activity tracked since 27 March 2026. The latest transaction was filed on 27 March 2026 (Purchase). Regulator: DART (FSS). All data is free.
Companies and markets linked to 허승범
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
허승범 is President and Chief Executive Officer at 삼일제약. He has 50 filings in total, and among the 50 most recent filings available, purchases total 30656 EUR and sales 0 EUR, with filings spanning 2021-04-16 to 2026-05-22. The modal transaction nature is Purchase.